Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
about
Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infectionGut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunityIncomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutionsMarkers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patientsKIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapyIncident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan AfricaCellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy durationMaraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression.Low cholesterol? Don't brag yet ... hypocholesterolemia blunts HAART effectiveness: a longitudinal study.Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease.Immune activation and HIV persistence: implications for curative approaches to HIV infection.Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+ T cellsImmune activation in HIV-infected aging women on antiretrovirals--implications for age-associated comorbidities: a cross-sectional pilot study.CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolutionSmall intestine CD4+ cell reduction and enteropathy in simian/human immunodeficiency virus KS661-infected rhesus macaques in the presence of low viral loadImmunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cellsRisk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAARTRole of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients.Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype.Brief Report: Role of Thymic Reconstitution in the Outcome of AIDS-Related PMLHIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 disease.Microbial translocation, immune activation, and HIV disease.Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatmentMicrobial translocation in the pathogenesis of HIV infection and AIDS.Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection.Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patientsInterleukin-7 promotes HIV persistence during antiretroviral therapy.HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trialDimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.The role of cytokines in the establishment, persistence and eradication of the HIV reservoirMaraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.Low Double-Negative CD3+CD4-CD8- T Cells Are Associated with Incomplete Restoration of CD4+ T Cells and Higher Immune Activation in HIV-1 Immunological Non-RespondersStimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral TherapyMicrobial translocation in HIV infection: causes, consequences and treatment opportunities.Immunodiscordant responses to HAART--mechanisms and consequences.Evaluation of the pharmacogenetics of immune recovery in treated HIV-infected patients.Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects.Discordance between peripheral and colonic markers of inflammation during suppressive ART
P2860
Q26748743-0754FFFC-BAA0-4190-B798-59F2372E54A8Q26773267-97D92704-BD1A-4347-BF89-DE505B31D86CQ27021524-0C1BABB2-53B5-49B7-A7DD-C33D9947BFC0Q27024262-1666D521-B6FF-4ABF-837D-DAE4A40D3468Q28477797-7687BF52-4AB6-424C-953F-CCDA985159C5Q33580153-C04EDBC6-5E2B-497F-A95D-3278EFC26D63Q33909555-DEBFBD16-B1DB-460E-AF5B-604912A2C98EQ33976854-0EED663D-3146-486A-88F3-E4F0ADA44BECQ34028922-81489A8D-5C97-4B3B-BFC5-34AE7EDDA859Q34229695-4EDB3B41-A8E2-4EFA-A7CA-8C50AAD81B5CQ34351320-8B345BDF-7E95-4F7E-86A3-3FFC5BC99EDAQ34719602-0CDE7DFF-69B1-4176-99EC-E2FE571CE4CFQ34749335-175E0EBA-48C6-4854-BA2A-25897FCFC61AQ35121645-143E08D1-8DA3-4304-933F-F3603899508AQ35336419-5CA2B155-7912-4FE4-B1AF-91D6049DD9DCQ35557198-E6D5FCDD-3D74-42D1-B039-47BAE2396E16Q35645143-AB9E7EEA-3CF7-426E-A65B-0B199C9071B7Q35780966-06F60692-D381-436B-B0C5-B9B930F824CBQ35856740-33D693CB-648B-4105-874C-FC673C6CF1C5Q35988556-A7A4D42E-0A80-49B8-AA9B-6DE7B3F859DAQ36220004-2D46D840-67AD-4C96-87CF-3AE8457E1EDCQ36279270-FB5EA0FA-D1A3-4378-8113-700F2E6F3AC0Q36501286-50D374E0-73F3-4A96-B0EA-788C171F0D68Q36554005-55FD66AA-0492-48D5-B692-464C032B8788Q36558287-AE7F283F-2B1F-42B8-9154-AD0A338F5111Q36678143-FACC4DA8-B2D8-4A42-A6FB-F22F1AB2E60FQ36688486-C80D6388-0117-4339-9114-E304B27AA790Q36873277-660A1825-A785-4B4C-A56D-AF159CEA2021Q36986644-D7597DE4-65D2-46B6-9075-BF948C4B09ADQ37122279-A7FA189E-D128-4744-B021-F56E74AD1D81Q37157209-11989600-A6E4-4BD0-8926-4EDB9D98B1E3Q37308894-1DA5E48E-5F18-4E7F-BE51-0ECBA519E7F8Q37362435-5B8A598D-6166-4F91-BB3A-441EAD1767C2Q37486642-3AD83359-E838-4295-B7CD-B02964BCF2C1Q37513027-1C163E10-EB0F-4F40-97FE-95EC098F4B39Q38034068-69A0CF58-ACF5-4D6C-8F40-3AF74AD77034Q38156230-1BBAF344-270A-4D4E-816F-321666052447Q38164430-B8473F3F-DD86-4EC5-BA3A-A7BA8824C525Q38619193-1326D9CC-163F-42F0-BFA8-464B9F6E2DEDQ38930864-5DFEF23C-5190-41C0-A704-66D8D4BD3C46
P2860
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Comparative analysis of T-cell ...... irological responses to HAART.
@en
Comparative analysis of T-cell ...... irological responses to HAART.
@nl
type
label
Comparative analysis of T-cell ...... irological responses to HAART.
@en
Comparative analysis of T-cell ...... irological responses to HAART.
@nl
prefLabel
Comparative analysis of T-cell ...... irological responses to HAART.
@en
Comparative analysis of T-cell ...... irological responses to HAART.
@nl
P2093
P50
P921
P1433
P1476
Comparative analysis of T-cell ...... irological responses to HAART.
@en
P2093
Anna Casabianca
Carlo-Federico Perno
Fabio Franzetti
Luca Meroni
Mauro Magnani
P304
P356
10.1097/01.AIDS.0000242819.72839.DB
P407
P577
2006-08-01T00:00:00Z